Free shipping on all orders over $ 500

Mabuterol

Cat. No. M40721
Mabuterol Structure
Size Price Availability Quantity
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Mabuterol is a selective, orally active beta-2 adrenergic receptor (β2-AR) agonist. Mabuterol inhibits PDGF-BB-induced cell proliferation, increased intracellular Ca2+, and Drp-1, cyclinD1, and PCNA protein expression, and enhances Mfn-2 expression. Can be used in studies of airway obstruction and chronic obstructive pulmonary disease (COPD).

Chemical Information
Molecular Weight 310.74
Formula C13H18ClF3N2O
CAS Number 56341-08-3
Form Solid
Solubility (25°C) DMF 30 mg/mL
DMSO 30 mg/mL
Ethanol 30 mg/mL
Storage -20°C
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Liuyang Wang et al. Int J Pharm. Development of mabuterol transdermal patch: Molecular mechanism study of ion-pair improving patch stability

[2] Yaru Gu et al. Chem Biol Interact. Inhibitory effect of mabuterol on proliferation of rat ASMCs induced by PDGF-BB via regulating [Ca2+]i and mitochondrial fission/fusion

[3] Xiumei Lu et al. Biomed Chromatogr. Enantioselective pharmacokinetics of mabuterol in rats studied using sequential achiral and chiral HPLC

[4] K Amemiya et al. Arzneimittelforschung. Toxicology of mabuterol

[5] I Yamamoto et al. J Immunoassay. Enzyme immunoassay for mabuterol, a selective beta 2-adrenergic stimulant in the trachea

Related Adrenergic Receptor Products
CRN04894

CRN04894 is an orally nonpeptide, potent and selective antagonist for adrenocorticotropic hormone (ACTH) acting at the melanocortin 2 receptor (MC2R). CRN04894 blocks the action of ACTH at MC2R, providing a potential novel treatment for the diseases of ACTH excess such as Cushing’s disease, congenital adrenal hyperplasia, and ectopic ACTH-secreting tumors.

(Des-His6)-ACTH (1-24) (human, bovine, rat)

(Des-His6)-ACTH (1-24) (human, bovine, rat) is an analogue of Adrenocorticotropic hormone (ACTH).

ACTH (1-14)

ACTH (1-14) is a fragment of adrenocorticotrophin, which regulates cortisol and androgen production.

Mibenratide

Mibenratide, a small cyclic peptide, is an adrenergic β1 receptor antagonist.

Conopeptide rho-TIA

Conopeptide rho-TIA is a peptide derived from the venom contained in the predatory sea snail Conus tulipa, has highly selective and noncompetitive inhibitor at human α1B-Adrenergic Receptor.

  Catalog
Abmole Inhibitor Catalog




Keywords: Mabuterol supplier, Adrenergic Receptor, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.